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Typical T  cells of the helper phenotype require that the foreign antigen be 
recognized in association with a  molecule encoded within the I  region of the 
mouse H-2 complex (1, 2), the Ia molecule (3, 4). Cells that bear such molecules 
and that are capable of activating T  cells in the presence of antigen are known 
as antigen-presenting cells (APC). 1 Although much is known of the tissue distri- 
bution of Ia molecules, the nature of the cells responsible for antigen presentation 
is not completely clear (5). The adherent, nonspecific esterase positive, radiore- 
sistant macrophage has been considered to be the prototypic APC (6-8). How- 
ever, studies  by  Steinman et al.  (9)  established  that splenic and  lymph node 
dendritic cells (Fc receptor negative, weakly adherent, nonspecific esterase neg- 
ative,  nonphagocytic cells) were capable of stimulating mixed lymphocyte re- 
sponses.  Sunshine et  al.  (10)  further  demonstrated that  dendritic cells  were 
capable of presenting soluble antigens to antigen-primed T  cells, as assessed by 
T  cell proliferation. Both hepatic K/ipffer cells (11) and epidermal Langerhans 
cells (12) have also been shown to be capable of acting as accessory cells for T 
cell activation. 
Attention has recently turned to the ability of B cells to present antigen to T 
cells (13,  14). It has been quite clearly shown that many B iymphomas possess 
APC activity (15-18). However, the antigen-presenting ability of normal B cells, 
particularly those in the resting state, remains uncertain. In 1981  Chesnut and 
Grey (19) investigated the ability of heavily irradiated (4,500 rads) macrophage- 
depleted  spleen  cells,  prepared  by  passage  over  Sephadex  G-10,  to  present 
antigen  to  antigen-primed  T  cells.  They  showed  that  T  cells  from  donors 
immunized with  rabbit  immunoglobulin (Ig)  proliferated  in  the  presence  of 
irradiated, syngeneic, macrophage-depleted spleen cells and rabbit anti-mouse 
Ig, but not with the original immunogen, normal rabbit Ig. In contrast, splenic 
adherent cells containing macrophages were capable of presenting both antigens 
equally well to the T  cells.  Since anti-Ig antibodies not only bind to mouse B 
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cells, but also activate them, these results left open the question of the ability of 
resting  B  cells  to  act as  APC.  Indeed,  Chesnut et al.  (18)  demonstrated that 
heavily irradiated LPS-activated B cell blasts were capable of presenting KLH to 
antigen-primed  lymph  node  T  cells  and  antigen-specific  T  cell  hybridomas, 
whereas similarly irradiated normal B cells were not. More recently both Katz et 
al. (20) and Bandeira et al. (21) reported that normal B cells, treated either with 
mitomycin c  or irradiation, failed to present ovalbumin (OVA) or minor histo- 
compatibility antigens to specific T  cell clones as measured by T  cell proliferation. 
However, both groups demonstrated that untreated normal B cells themselves 
proliferated in the presence of specific T  cells and antigen, implying that the B 
cells could act as APC  for T  cell activation leading to  "recruitment" of B  cell 
proliferation.  These  studies suggest that under some circumstances,  resting B 
cells  can  present  soluble  antigen  to  antigen-specific,  MHC-restricted  T  cells. 
However, the ability of untreated resting B  cells to present antigen for T  cell 
proliferation,  still  remains  uncertain.  Furthermore,  little  is  known  about  the 
• heterogeneity of the T  cell response to B cells as APC. 
In this paper we examine the ability of small resting B cells to act as APC to 
antigen-specific  long-term  in  vitro  T  cell  clones  and  lines  as  well  as  freshly 
explanted lymph node T  cells. We report three new observations: (a) some, but 
not  all,  MHC-restricted  T  cells  can  be  induced  to  proliferate  (or  to  make 
interleukin 2 [IL-2]) in the presence of lightly irradiated B cells plus the appro- 
priate foreign antigen,  (b)  in  contrast  to  macrophages and dendritic cells,  the 
antigen-presenting function of small resting B cells is very radiosensitive, and (c) 
APC can activate two distinct pathways in responding T  cells, one that leads to 
proliferation  of the  T  cell,  and  the  other  that  leads  to  B  cell  activation  and 
proliferation. 
Materials and Methods 
Animals.  B10.A/SgSn  (BI0.A)  mice  were  obtained  from  Harlan  Sprague-Dawley 
(Madison, WI). B10.S(9R),  B10.RIII, and B10.BR mice were the progeny of breeding 
pairs originally provided by Dr. Jack Stimpfling, McLaughlin Research Institute, Great 
Falls, MT. They were Caesarian-derived into our breeding colony by fostering on NIH 
General Purpose mice and subsequently propagated by brother-sister mating. 
60  ~0  10  Antigen.  The random terpolymer, poly-(Glu  Aia  Tyr  ), (GAT) was purchased from 
Vega Biochemicals,  Tucson, AZ. Pigeon cytochrome c was purchased from Sigma Chem- 
ical Co., St. Louis, MO and purified on carboxymethyl cellulose as previously described 
(22). Cytochrome c cyanogen bromide cleavage fragment 81-I 04 was prepared as previ- 
ously described (23) and provided by Dr. L. Samelson of our laboratory. Hen egg lysozyme 
(HEL) was purchased from Sigma Chemical Co. 
Monoclonal Antibodies.  Anti-Thy-l.2 was purchasd from New England Nuclear, Bos- 
ton, MA. Anti-Lyt-1 (53.7.3) and anti-Lyt-2 (53.6.7)  were prepared from hybridomas 
derived by Ledbetter and Herzenberg (24).  MAR  18.5,  a  murine anti-rat kappa chain 
monoclonal antibody, was prepared from a hybridoma derived by Lanier et al. (25). The 
cells from which these antibodies were prepared were provided to us by Dr. John Kung 
of our laboratory. 
Cell Preparations.  Spleen cells from unprimed mice were incubated with anti-Lyt-l, 
anti-Lyt-2, and anti-Thy-l.2 for 30 min at 4°C. They were centrifuged and resuspended 
in  guinea pig  complement (1:4  dilution,  Flow  Laboratories,  Rockville,  MD)and  the 
monoclonal antibody MAR 18.5, to increase the cytotoxicity of the anti-Lyt-1 and anti- 
Lyt-2 antibodies. The cells were incubated for 30 rain at 37°C, then washed in RPMI 
1640.  This population is referred to as T-depleted spleen cells. After T  cell depletion, ASHWELL ET  AL.  883 
the cells were separated on a Percoll density gradient as previously described (26). The 
low density fraction (layering above the  50%  Percoll layer, density <1.062  g/ml),  has 
been shown to consist of ~50% IgM-bearing cells and 40-50% latex bead-ingesting cells. 
It is enriched in radioresistant APC activity. The high density cells (layering between the 
60% and 70% Percoll layers, density between 1.074 g/mi and  1.086 g/ml) is composed 
of ~80% surface IgM-bearing cells, which have been shown to be resting B cells by several 
criteria (26). Stimulation of these cells with concanavalin A was performed as control for 
T  cell depletion in every experiment and never caused any measurable proliferation in 
this cell population.  These cells will  be  referred to as  small  resting  B  cells.  In  some 
experiments the  high  density cells were further purified by passage  over columns of 
Sephadex G-10 (G-10-passed B cells) (27). Cells that did not bind to the Sephadex G-10 
column were further purified in some cases by adherence at 4°C to petri plates (Corning, 
100-mm tissue culture) coated with  10 ug/ml of affinity-purified goat anti-u,  7 ml per 
plate (panned B cells) (28). Cytofluorometric analysis of these cells using goat anti-mouse 
light chain antisera demonstrated that the cells recovered after passage over Sephadex G- 
10 were ~95%  Ig-bearing cells,  and the cells recovered after panning were >99%  Ig- 
bearing cells. 
Radiation  of Cells.  All irradiation was delivered from a  137Cs source (Gammator M; 
Isomedix Inc., Parsippany, N  J). Different doses were administered by varying the exposure 
time at a fixed distance from the source. 
Immunizations.  Immunizing antigens were emulsified in complete Freund's adjuvant 
(H37Ra, Difco Laboratories, Detroit, MI) and injected subcutaneously into the footpads 
and at the base of the tail in a  total volume of 150 ul.  Cells  were obtained from the 
draining lymph nodes 7-10 d later and enriched for T  cells by passage over nylon wool 
columns  (29).  T  cells prepared  in  this  manner  for proliferation assays  were  further 
depleted of APC by treatment with two anti-Ia monoclonal antibody supernatants (10- 
2.16 (30) and  M5/114  (31), anti  I-A  k and  I-E  k,  respectively) plus complement. These 
antibodies were kindly provided by Dr. Gen Suzuki of our laboratory. 
In Vitro Cell Culture.  T ceils obtained from immunized animals were cloned by limiting 
dilution and  maintained  in  vitro by cycles of stimulation  with antigen and  irradiated 
(3,300 rads) syngeneic spleen cells, followed by a period of rest in the absence of antigen 
in the manner of Kimoto and  Fathman  (32).  The cells  were grown in a  1:1  (vol/vol) 
mixture of RPMI  I640 (Biofluids, Inc., Rockville, MD) and Eagle's-Hanks's amino acid 
(EHAA) medium prepared in the NIH media unit. This mixture was supplemented with 
10% fetal calf serum, 4 mM glutamine, 100 U of penicillin, and 50 uM 2-mercaptoethanol 
(complete medium). The cells were not exposed to an exogenous source of IL-2 after 
they were cloned. The T  cell clone 11.4 was established by soft agar cloning after the 
technique of Sredni and Schwartz (33). Unlike the other normal T  cells used in these 
experiments, 11.4 was maintained solely with complete medium supplemented with 5% 
concanavalin A-stimulated rat spleen supernatant as a source of IL-2. Neither antigen 
nor filler cells  were added.  11.4 responds  to the antigen GAT in  the context of the 
k.  k  A~.A, Ia molecule. It is also alloreactive to H-2 r, but not to any Ia molecules encoded by 
the H-2 *'d'q'u'bx't4 haplotypes. 
T  cell  hybridomas were  established  as  previously described  (34).  Briefly, antigen- 
stimulated T cell blasts were mixed with the hypoxanthine-aminopterin-thymidine-sensi- 
tive T  cell line BW5147 in the presence of polyethylene glycol 1000 (Baker Chemical 
Co., Phillipsburg, N  J) 50% (vol/vol) for 8 min. 5 ×  105 cells were then plated into 96-well 
Costar plates (#3596) containing 5 ×  103 irradiated (2,500 rads) peritoneal wash-out cells. 
6  d  later hybridomas were  picked and  transferred  to  24-well  Costar plates  (#3524), 
expanded, and tested for antigen-specific IL-2 production. All antigen-specific hybridomas 
were subcloned twice before being used in experiments. 
T  Cell Proliferation Assay.  Varying numbers of T  cells were incubated in 96-well flat- 
bottomed microtiter plates (Costar #3596), with different APC populations and antigen 
in  a  final  volume  of 200  ul.  Assays  were  performed  in  Iscove's/F12  medium  (35) 
supplemented with 10% fetal calf serum. After 48 h the cultures were pulsed with 1 uCi/ 
well  of tritiated  thymidine  (6.7  Ci/mmol,  New  England  Nuclear,  Boston,  MA)  and 884  ANTIGEN  PRESENTATION BY  RESTING B CELLS 
harvested 16 h later (PHD cell harvester, Cambridge Technology, Inc., Cambridge, MA). 
Determinations were done in duplicate and the data expressed as the arithmetic mean. 
Standard errors of the mean were routinely <15%. All experiments included an irradiated 
T cell control to ensure that the measured tritiated thymidine incorporation was due to 
T cell uptake. 
IL-2  Assay.  The response  of T  cell  hybridomas to stimulation was assessed  by the 
ability of culture supernatants to cause the proliferation of an IL-2-dependent T  cell 
clone, HT-2, as previously described (29). 
B Cell Proliferation Assay.  Irradiated T  cells were cultured with various B cell popula- 
tions in the presence or absence of additional filler cells and antigen in 96-well plates 
(Costar #3596). After 24 h the wells were pulsed with tritiated thymidine and harvested 
-16 h later, as above. This roughly corresponds to the first round of replication of these 
cells. The optimum amount of irradiation required to abrogate T cell proliferation in the 
presence of  antigen varied from 2,000 to 3,300 rads and had to be individually  determined 
for each  T  cell  clone.  Assays  were  performed  in  duplicate  in  Iscoves/F12  medium 
supplemented with  10%  fetal calf serum.  Standard errors of the mean were routinely 
<15%. 
Cell Size Analysis.  Cell size profiles were analyzed using a Coulter Counter as described 
elsewhere (26). 
Results 
Small  Resting B  Cells  Can  Present Soluble Antigen  to  an MHC-Restricted  T  Cell 
Clone.  We tested the ability of resting B cells to act as APC to an MHC-restricted 
T  cell clone. Spleen cells from nonimmune B10.A mice were depleted of T  cells 
by anti-T  cell  antibody and  complement  treatment and  then  fractionated by 
density on a discontinuous Percoll gradient. Two cell populations were removed 
from the gradient for analysis as APC: the high density cells that layer between 
the 60% and 70% layers of Percoll and that have been shown to be enriched for 
small  resting  B  cells  (26),  and  the  low  density,  dendritic-  and  macrophage- 
enriched  cells  that  layer above  50%  Percoll.  In  these  experiments  the  small 
resting B cells were then passed over a Sephadex G-10 column to further deplete 
them of any contaminating macrophages. The cells recovered from the Sephadex 
G-10 column were cultured with the T  cell clone A.5.1 at a B:T ratio of 10:1 in 
the presence  or absence of GAT. The  B10.A-derived,  long-term T  cell clone, 
,  Aa.A~ Ia molecule in association with the  A.5.1  responds  to APC bearing the  k.  k 
random  terpolymer,  GAT,  by  both  proliferating  and  by  causing  polyclonal 
activation and proliferation of resting B cells (36,  unpublished observation).  B 
cell activation is conveniently measured by increase in cell volume. 
Size profiles of the cell populations were determined after 24 h in culture (Fig. 
1). The G-10-passed B cells themselves were of a relatively uniform size (median 
114/~m3),  which did not appreciably change with the addition of either T  cells 
(116/~m  ~) or dendritic- and macrophage-enriched cells (120 ~m  ~) in the absence 
of GAT. However, the addition of GAT to the mixture of A.5.1 and syngeneic 
B cells was sufficient to cause a polyclonal enlargement of the B cells in culture 
(median of 152 ~m  ~) in the absence of  added low density cells. The size histograms 
demonstrate  that all of the  cells  in  the  culture  were  enlarged,  ruling out the 
possibility that only the T  cells responded.  In addition, mixing experiments, in 
which T  cells were activated separately from resting B cells and then added back 
just before size analysis, confirmed that at a ratio of 10:1 the contribution to the 
size enlargement made by the T  cells was quite small (data not shown). It should ASHWELL  ET  AL.  885 
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FIGURE  1.  Size enlargement of small resting B cells induced by an antigen-activated T  cell 
clone. G-10-passed B cells were isolated from B10.A spleen cells after T  cell depletion and 
separation on a  Percoll density gradient. All cells were unirradiated. Cell numbers used per 
well: small B10.A B cells,  1 X  108; T  cell clone A.5.1,  1 x  105; B10.A low density APC, 5 X 
104. Cell size was measured on a  Coulter Counter 23  h  after mixing the cells and antigen. 
GAT was used at a final concentration of 100 #g/ml. 
be  noted  that  in  the presence of antigen  the addition  of 5  x  104  irradiated 
dendritic- and macrophage-enriched APC had no additional effect on the size 
enlargement of the B cells (152 #m~). This indicates that either the culture was 
already saturated for antigen-presenting activity, or that the irradiated dendritic- 
and macrophage-enriched cells did not play a role in the presentation of antigen 
for B cell enlargement. 
The ability of Sephadex G-10-passed B cells to act as APC for T cell activation 
resulting in their own recruitment was also assessed by measuring [~H]thymidine 
incorporation  by  B  cells.  2  x  10  4  irradiated  A.5.1  T  cells (2,000  rads)  were 
incubated with 2 x  105 Sephadex G-10-passed B10.A B cells in the presence or 
absence of GAT (Table IA). The unirradiated B cells proliferated vigorously in 
the presence, but not in the absence, of GAT. The response was demonstrated 
to be due to B cell, and not T  cell, thymidine incorporation by the observation 
that  1,000 rads delivered to the B cell population abrogated the incorporation 
of [SH]thymidine. 
The ability of the Sephadex G-10-passed resting B cells and the dendritic- and 
macrophage-enriched cells  to  act  as  APC  for  T  cell  proliferation  was  also 
examined (Table IB). Both lightly irradiated (1,000 rads) Sephadex G-10-passed 
B cells and heavily irradiated (3,300 rads) dendritic- and macrophage-enriched 
cells were capable of presenting GAT to A.5.1 as assessed by T  cell proliferation. 
The T  cell proliferation was dependent on the addition of a source of APC as 
well as the presence of GAT. Thus, small resting B cell populations, even after 
passage over Sephadex G-10, appeared to be able to present soluble antigen to 
T  cells both for T  cell proliferation and B cell recruitment. 
Ability of  B Cells to Present Antigen Is Radiosensitive.  The observation that resting 886  ANTIGEN PRESENTATION BY  RESTING B CELLS 
TABLE  I 
Ability of Different APC to Present GAT to the T Cell Clone A.5. l for T Cell and B Cell 
Proliferation 
APC added  Antigen 
Sephadex G-10 B  GAT: 
cells (unirra-  Sephadex G-10 B  Low density cells 
diated)  cells (1,000 rads)  (3,300 rads)  _  + 
A.  B cell proliferation 
(T cells irradiated) 
2x 105 
--  2X lO  s 
B.  T cell proliferation 
(T cells unirradiated) 
--  1  x  lO  s 
[SH]Thymidine incorporation 
cpm 
3,500  37,200 
ND*  1,600 
cpm 
--  2,900  2,700 
--  2,400  86,000 
2 x  104  2,400  75,800 
A.  2 x  10  ~ A.5.1 T cells were given 2,000 rads and then incubated with the indicated number of 
Sephadex G-10-passed B cells in the presence or absence of GAT (100 ~g/ml). Sephadex G-10- 
passed B cells were isolated from B10.A spleen cells after T cell depletion, separation on a Percoll 
density gradient (p = 1.074-1.086),  and passage over a Sephadex G-10 column. B cell proliferation 
was measured by pulsing the wells with ['H]thymidine after 24 h and harvesting them 16 h later. 
B.  2 X 104 unirradiated  A.5.1 T  cells were incubated with the indicated number of APC in the 
presence or absence of GAT (100 ~g/ml). Low density cells were isolated from the same source 
after T cell depletion and separation on the Percoll density gradient (p _> 1.062). Sephadex G-10- 
passed B cells were isolated as in Part A. T cell proh%ration was measured by pulsing the wells with 
[SH]thymidine after 48 h and harvesting them 16 h later. 
* Not determined. 
B cells could present antigen to MHC-restricted T  cells did not agree with earlier 
reports from Grey and  colleagues (18,  19).  Since one of the  major differences 
between their assay systems and  ours is the  amount of irradiation  delivered to 
the APC, we explored the radiation sensitivity of the antigen-presenting function 
of Sephadex G- 10-passed B cells as compared to the known in vitro radioresist- 
ance  of this  function  in  dendritic-  and  macrophage-enriched  cells  (7,  17,  37). 
Table II contains  the  results of an experiment in which  the  T  cell clone A.5.1 
was assayed for its ability to proliferate when stimulated with GAT in the presence 
of either Sephadex G-10-passed B  cells or dendritic- and macrophage-enriched 
cells  that  had  been  treated  with  varying doses  of irradiation.  The  amount  of 
[3H]thymidine  incorporation  attributable  to T  cells was taken as the difference 
in uptake of cultures containing unirradiated and irradiated (2,500  fads) T  cells. 
A.5.1  T  cells  proliferated  well  in  the  presence  of GAT  when  either  G-10- 
passed B  cells or low density cells were  used as APC (Table  II). It is also clear 
that  the  antigen-presenting  ability  of the  B  cells  was  radiosensitive;  doses  of 
irradiation  in  excess of 1,000  rads  markedly reduced  their stimulatory activity 
and  3,300  rads  abolished  it.  In  contrast,  the  antigen-presenting  ability of the 
dendritic cell and macrophage-enriched population was only slightly affected by 
irradiation.  The small decrease in antigen presentation  by these cells at 2,000- 
3,300  fads may reflect  the  contribution  of the  B  cells in  this population  to  its 
overall antigen-presenting ability. 
Although this experiment allowed us to conclude that the ability of B cells to ASHWELL  ET  AL.  887 
TABLE  II 
Effect  of lrradiation on Different APC 
Sephadex G-10  Low density cells  Irradiation to  Irradiated A.5.1  T cell prolifera- 
B cells  APC  (2,500 rads)  tion 
2x l0  s 
5  ×  10  4 
rads  cpm  ~ cpm 
500  5,810  30,800 
1,000  1,600  29,600 
1,500  1,150  10,800 
2,000  1,000  2,200 
3,300  1,500  200 
500  1,950  86,600 
1,000  1,050  88,000 
1,500  900  84,600 
2,000  1,200  68,600 
3,300  1,200  73,200 
2 ×  104 A.5.1 T cells were incubated with the indicated number of APC (see Table I for a 
description of the two APC populations) in the presence of GAT (100 ~g/ml). As a control, 
A.5.1 cells were irradiated with 2,500 rads to determine how much of the total response was 
due to residual recruited B cell proliferation (which is expected at low doses of irradiation). T 
cell proliferation was calculated by subtracting this amount from the total amount of [SH]- 
thymidine incorporated (Acpm). 
stimulate T  cells to proliferate in the presence of antigen was radiosensitive, we 
could not determine from it the radiosensitivity of B cells as APC in the T  cell- 
driven induction of B cell recruitment. In order to characterize the ability of B 
cells to present antigen  for subsequent  B  cell recruitment, it was  necessary to 
separate the B cell's ability to act as an APC when irradiated, from its ability to 
respond to a proliferative stimulus.  In order to do this, use was made of the fact 
that  antigen-activated  T  cells  could  cause  B  cell  proliferation  in  an  MHC- 
unrestricted manner.  As described in the accompanying paper (36), the B10.A- 
derived,  GAT-specific  T  cell  clone,  1 1.4,  when  stimulated  by  GAT  in  the 
presence of syngeneic irradiated APC,  causes B10.S(9R) B cells to enlarge and 
proliferate. Treating  1 1.4 T  cells with 2,000 rads eliminates the T  cell's ability 
to  proliferate  when  stimulated  with  GAT  in  the  presence  of the  appropriate 
APC, but not its ability to recruit B10.S(9R) B cells to proliferate. The prolifer- 
ative response of the B10.S(9R) B cells was shown to be directly related to the 
number of 1 1.4 T  cells and the number of syngeneic APC in the culture, as well 
as to the concentration of GAT (36).  The B10.S(9R) B  cells, in the absence of 
syngeneic B cells, do not proliferate, presumably because they can not function 
as APC to activate the T  cell clone. 
The  effects of irradiation  on  the  ability  of syngeneic B  cells to successfully 
present antigen to irradiated  1 1.4 T  cells to in turn cause [3H]thymidine incor- 
poration by unirradiated allogeneic B10.S(9R) B  cells is shown in Fig.  2.  Panel 
A  shows  the  effects of irradiation  to  the  syngeneic  B10.A  B  cell  on  its  own 
proliferative response to  LPS.  500  rads  reduced  the  response  by  80%;  1,000 
rads almost totally eliminated it.  Panel B shows a  similar pattern when antigen- 
stimulated,  irradiated,  11.4 T  cells were used as the stimulus for the syngeneic 
B cell proliferation. These control experiments show that 1,000 rads is sufficient 
to eliminate most of the contribution of syngeneic B cells to any measured [aH]- 888  ANTIGEN  PRESENTATION  BY  RESTING  B  CELLS 
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FIGURE 2.  Effect of irradiation  on B cell APC function.  The [SH]thymidine incorporation of 
stimulated  B cells was determined as a  function of the amount of irradiation  delivered  to 
syngeneic B 10.A B cells. The amount of proliferation measured at each dose of irradiation  is 
displayed  as  a  percentage of the  response  of the  unirradiated  cells for each  group.  The 
numbers under each bar represent the amount of irradiation  given to the B 10.A B cells. The 
number over the first bar of each panel  represents  the CPM incorporated in the absence of 
any irradiation.  Panel  A.  2 ×  105 B10.A  small resting B cells were treated with different 
amounts of radiation  and then incubated with LPS (50 ~g/ml).  Panel B. 2 ×  105 small resting 
B10.A B cells were treated with different amounts of radiation and then incubated with 2 × 
104 11.4 T cells (treated with 2,000 rads; 11.4x) and GAT (100 t~g/ml). Panel C. 2 × 105 small 
resting B10.A B cells were incubated with 2 × 10  s allogeneic B10.S(9R) B cells in the presence 
of 2 ×  104 irradiated  11.4 T  cells and GAT (100 t~g/ml). Varying doses of irradiation were 
given to the syngeneic B10.A B cells and not to the allogeneic  B10.S(9R) B cells. The bars 
represent the amount of proliferation of the B10.S(9R) B cells only. This was calculated  by 
subtracting the CPM incorporated by the B10.A  B cells at the same amount of irradiation 
(panel B) from the total amount measured when the B 10.A and B 10.S(9R) B cells were mixed 
together. For example, the total CPM incorporated by the mixture of the two types of B cells, 
with no irradiation to the B10.A B cells, was 156,480. 
thymidine  incorporation.  In  panel  C,  irradiated  syngeneic  B10.A  and  unirra- 
diated aliogeneic B10.S(9R) B cells were mixed together in equal numbers in the 
presence of irradiated  11.4 T  cells and antigen.  The amount of allogeneic B  cell 
[~H]thymidine incorporation,  calculated by subtracting the known small amount 
of B 10.A B  cell [SH]thymidine incorporation induced by antigen-activated  11.4 
T  cells from the total  [3H]thymidine  incorporation,  is graphed as a  function  of 
the  radiation  dose  given  only to the  syngeneic  B10.A  B  cells.  As the  B10.A  B 
cells,  which  were  the  only  syngeneic  APC  in  the  culture,  were  given  larger 
radiation  doses,  the proliferation  of the allogeneic  B  cells decreased.  By  3,300 
rads there was >90%  reduction in the amount of B 10.S(9R) B cell [SH]thymidine 
incorporation.  Thus,  the  APC  function  of  syngeneic  B  cells  for  allogeneic 
recruitment  is  also  radiosensitive,  although  less  so  than  the  syngeneic  B  cell's 
own proliferative response.  It is this difference in radiosensitivity that allowed us 
to assess the B cells APC function in the absence of its own response. 
Overall,  these  data  indicate  that antigen  presentation  by small  resting  B  cells 
for both T  cell proliferation and initiation of B cell recruitment is a radiosensitive ASHWELL  ET  AL.  889 
function. This B  cell trait is distinct from the radioresistance of dendritic cell 
and macrophage APC function. Therefore radiation dose provides a useful way 
to distinguish between the two cell types in antigen-presentation assays. 
Highly Pur~ed B Cells are Potent APC  for B Cell Recruitment.  It might be argued 
for  syngeneic  recruitment,  where  the  B  cells  are  not  irradiated,  that  small 
numbers of contaminating macrophages and/or dendritic cells in the Sephadex 
G-10-passed B cell population were responsible for the antigen-presenting activ- 
ity observed. To test this,  highly purified panned B10.BR  B cells, which were 
>99% Ig-bearing cells by flow microfluorometric analysis, were used to stimulate 
the T  cell clone 11.4, which had been grown only on IL-2-containing superna- 
A~:A, Ia molecule for which 11.4 T  cells are "co-  tants. B10.BR cells possess the  k  k 
specific," and  thus should be  capable  of presenting GAT  to  11.4  T  cells.  In 
addition, advantage was taken of the fact that  11.4 T  cells are also alloreactive 
to H-U-encoded molecules, expressed by B10.RIII  B cells. The experiment in 
Table  III  demonstrates that panned B  cells, both  B10.BR  in  the presence of 
GAT (Acpm 37,100),  and B10.RIII  by themselves (Acpm 8,700),  were quite 
effective in inducing 11.4 T  cells to cause proliferation of the stimulatory B cells 
in the absence of any other accessory cells. 
In order to quantitate the ability of panned B cells to function as APC for T 
cell activation, 11.4 T cell-dependent [3H]thymidine incorporation by B 10.S(9R) 
B cells was measured as a function of the number of irradiated, panned B 10.A 
B cells (Fig.  3, A and B).  By utilizing the recruitment of B10.S(9R)  B cells to 
measure the response, we were able to keep the number of 11.4 T  cells and of 
the responding B10.S(9R) B cells constant while varying the number of panned 
B10.A B cell APC. The B10.A B cells were treated with 1,000 rads to abrogate 
their own proliferation but not their ability to function as APC. 
The  response  of B10.S(9R)  B  cells  depended  upon  the presence of GAT. 
Without antigen, [~H]thymidine incorporation at each dose of panned B10.A B 
cells was between 8,500-10,000  cpm. At the dose of GAT used (100 #g/ml) the 
antigen-presentation capability of the panned B 10.A B cells was maximal (94,000 
cpm) at about 1 ×  105 B cells per microtiter well. When the number of B10.A B 
cells was reduced below this value, the stimulated [~H]thymidine incorporation 
of B10.S(9R)  B  cells fell with a  slope of ~0.76  in  panel A and  0.80  in panel 
TABLE  III 
Pur~ed B Cells Can Be Recruited without Additional APC 
Mitogen  T  cell  GAT 
Proliferation (cpm) +  SEM of panned B cells 
B10.BR  B10.RIII 
--  --  --  1,100 (-+ 30)  1,200(_+ 110) 
LPS  --  --  94,300 (_ 6,840)  91,900 (+ 1,550) 
Con A  --  --  700 (+ 100)  600 (+ 190) 
--  2 x  104  --  3,800 (+ 480)  12,500 (+ 400) 
--  2  x  104  +  40,900 (+ 180)  13,600 (+ 20) 
Irradiated (2,000 rads) 11.4 T  cells were incubated with panned purified B cells from either 
B10.BR mice (syngeneic at the I region) or B10.RIII mice (to which 11.4 is alioreactive). B 
cell  proliferation  was  assessed  by  the  incorporation  of  [nH]thymidine.  The  proliferation 
measured in the presence of irradiated 11.4 T  cells, GAT, and B cells treated with 1,000 rads 
was 316 cpm for B10.BR and 368 cpm for B10.RIII. A  1,000 rad panned B 
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AUogeneic B cell proliferation  induced  by the T  cell  11.4  in  the presence  of 
various numbers of lightly irradiated panned B 10.A B cells.  2 x  104 11.4 T  cells (2,000 rads) 
were incubated with 2 ×  105 B 10.S(9R) small resting B cells with varying numbers of panned 
B10.A B  cells (1,000  rads)  plus  GAT (100  #g/ml).  Culture  of allogeneic BI0.S(9R) small 
resting B cells with irradiated  11.4 T  cells in the absence of GAT and syngeneic BI0.A small 
resting B cells resulted in the incorporation of I 1,560 cpm. Addition of GAT did not increase 
this number. Proliferation in the absence of GAT at each dose of syngeneic B cells added did 
not exceed 12,000  cpm.  The slope of the linear regression line from 3  X  l0 s to  1.2  ×  105 
panned B cells is 0.76 in panel A and 0.80 in panel B.  In panel B (O---O) is the proliferation 
observed when the panned BI0.A B cells were irradiated with 3,300 rads. ([]) is the prolifer- 
ation observed when irradiated (3,300 rads) low density cells were used as APC. 
B  (determined  from  the  linear  regression  line  of a  log-log plot  of cell  num- 
ber  vs.  Acpm).  Detectable  stimulation  of  [3H]thymidine  incorporation  by 
B10.S(9R) B cells was observed with as few as 2 x  103 irradiated  B10.A B cells. 
The fact that the slope of the log-lot plot of the dose-response curve was close to 
1 indicates  that only one limiting cell type in the  B10.A B cell population  was 
being titered into the culture.  Panel B further illustrates  that  panned B10.A B 
cells treated with 3,300 rads failed to act as APC for the activation of 11.4.  In 
contrast,  low density cells treated with 3,300 rads were potent APC. Thus, the 
APC function of the panned  B cells showed a  similar radiosensitivity to that of 
the G10-passed B cells. 
Finally, a quantitative comparison of APC function between lightly irradiated 
(1,000 rads),  Sephadex G10-passed B cells, and heavily irradiated  (3,300 rads) 
low density macrophage and dendritic cells is shown in Fig. 4. In this experiment 
the two populations were identical  in their capacity to present GAT to  11.4 T 
cells for the stimulation of [~H]thymidine incorporation by B 10.S(9R) B cells. In 
three other experiments the two populations were also found to be comparable 
on a per cell basis. These results argue strongly that  the APC activity of G10- 
passed B cells can not be due solely to contamination with a small number of low 
density cells.  Furthermore,  the complete radiosensitivity of the highly purified 
panned B cells argues strongly that the only APC in this population is a B cell. 
B Cells Can Present Antigen for Stimulation of T Cell Proliferation  to Some, But Not 
All,  T Cell Clones.  The T  cell clone, A.5.1, could be stimulated both to prolif- z  12 
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FIGURE 4.  Heavily irradiated low density cells and lightly irradiated G-10-passed B cells are 
equally potent as APC for inducing allogeneic B cell recruitment by  11.4 T  cells.  2  x  104 
irradiated (2,000  rads)  11.4 T  cells were incubated with 2  X  105 B10.S(9R) small resting B 
cells in  the presence  or absence  of GAT (100  #g/ml).  Allogeneic B  cell proliferation was 
measured  as a  function  of the  number  of B10.A  APC  titrated  into culture.  (O--O),  Low 
density B10.A cells (3,300 fads), ((g---O), Sepbadex G-10-passed B cells (1,000 rads). 
erate  and  to  recruit  B  cells  to  proliferate  when  stimulated  with  antigen  and 
purified B cells as APC. This was in contrast to the results of Katz et al. (20) and 
Bondeira et al. (21), who found that B cells could not induce a T  cell proliferative 
response.  In order to determine whether A.5.1  was an unusual  T  cell that had 
the capability of proliferating  in the presence of its antigen and resting B cells 
(Tables I and II), a number of normal T  cell clones as well as T  cell hybridomas 
were assayed for such responsiveness (Table IV).  12 normal  T  cell clones and 
one T  cell line were assayed for their ability to proliferate in the presence of the 
appropriate foreign antigen and lightly irradiated  (1,000 rads) Sephadex G-10- 
purified  small  B  cells or heavily irradiated  (3,300  rads)  dendritic-  and  macro- 
phage-enriched cells. Because B cells are poorer as APC for T  cell proliferation 
than  macrophage-enriched  cells  (see  below),  the  number  of B  cells  used  to 
stimulate the T cells was from 4-10-fold greater than the number of macrophage- 
enriched  cells.  All T  cells tested were derived from  B10.A  mice.  The  T  cell, 
11.4, was grown in the presence of IL-2 containing, rat spleen Con A supernatant; 
the remaining  cells were grown by serial  stimulation  with  soluble antigen  and 
irradiated (3,300 rads) spleen cells alternating with periods of rest in the absence 
of antigen. 
Of the  13  T  cell  lines  tested,  9  responded  with  substantial  [SH]thymidine 
incorporation  when stimulated with antigen and Sephadex G-10-passed B cells 
(Table IV). That the response of these T  cells was due to the APC activity of B 
cells  was  shown  by  the  radiosensitivity  of the  presenting  activity  of this  cell 
population  (Table IV, Expt.  2).  Four clones (numbers  10-13) showed little  or 
no [~H]thymidine incorporation in response to B cells, but did respond well when 
irradiated  (3,300  rads)  dendritic-  and  macrophage-enriched  cells were used as 
APC. The very small amount of [SH]thymidine incorporation observed in these 892  ANTIGEN  PRESENTATION  BY  RESTING  B  CELLS 
TABLE  IV 
Clonal Analysis of T Cells Capable of Proliferating in Response to Antigen Presented on Resting 
B Cells 
T  cell 
Sephadex G-10 B  Sephadex G-10 B  Low density cells 
cells (1,000 rads):  cells (3,300 rads):  (3,300 rads): 
Antigen  Antigen  Antigen 
-  +  -  +  -  + 
cpm  cpm  cpm 
Expt. 1 
1  PC.3 ST  300  17,900  --*  --  560  23,180 
2  PC.3.3  350  126,420  --  --  1,110  122,630 
3  PC.3H  220  4,800  --  --  180  5,600 
4  PC1.K  300  20,270  --  --  500  74,200 
5  PC.3A  240  57,030  --  --  210  61,000 
6  PC.3L  170  93,700  --  --  130  88,400 
7  PC 1B  320  24,000  --  --  140  162,000 
8  PCI.lp  280  21,000  --  --  120  38,400 
9  A1  810  86,600  --  --  210  50,160 
10  GAT.25.58a  300  1,900  --  --  --  52,100 
11  PC.3D  660  2,300  --  --  --  48,200 
12  PC.3.1  220  470  --  --  200  6,940 
13  11.4  330  870  --  --  160  15,600 
Expt. 2 
1  PC.3 ST  240  15,150  100  550  600  42,800 
2  PC.3.3  940  7,900  330  560  570  15,720 
3  PC.3H  380  29,100  170  2,550  330  49,500 
4  PC1.K  270  7,390  580  400  520  14,800 
5  PC.3A  300  30,120  230  780  300  32,660 
6  PC.3L  310  32,440  320  730  330  36,870 
7  PC1B  480  8,300  580  1,100  210  61,000 
* Not determined. 
13  normal in vitro T  cell  lines were  cultured at 2  ×  104  cells per well  in the presence of either 
Sephadex G-10-passed B10.A B cells (1,000 or 3,300 rads) or B10.A low density cells (3,300 rads). 
All cells were  tested for a  proliferative  response to the relevant foreign antigen, either GAT  or 
pigeon cytochrome c. The ratio of Sephadex G-10-passed B  cells to low density cells was at least 
4:1  and in most cases 10:1. The range of low density cells used was 3  ×  104 to  1 x  105, while the 
range of Sephadex G-10-passed B cells used was 2  ×  103 to 5  ×  105.  All T  ceils tested were cloned 
with the exception of A 1, which is a  T  cell line. 
four  cultures  in  the  presence  of lightly  irradiated  B  cells  plus  antigen  was 
consistent with a small amount of B cell recruitment. Overall, the experiments 
on T  cell clones suggest that there are two subpopulations of T  cells: one that 
can proliferate when either B cells or low density, radioresistant macrophages 
and dendritic cells are used as APC and the other, which can only be stimulated 
to proliferate when marophages and dendritic cells are used as APC. 
Four T  cell hybridomas were also tested for their ability to respond to B cells 
as APC (Table V). Two measures of T  cell activation were used: IL-2 secretion 
and recruitment of syngeneic B cell proliferation. The T  cell hybridomas were 
treated  with  10,000  rads  so  that  they would  not  incorporate  thymidine and 
interfere with the B cell proliferation assay. All the T  cells produced IL-2 when 
dendritic- and macrophage-enriched cells were used as APC. Three of the four 
hybrids responded to small resting B cells  in the presence of antigen (HEL or ASHWELL  ET  AL.  893 
TABLE  V 
Ability ofT Cell Hybridomas to Respond to Different APC by the Production of lL-2 and the 
Recruitment of B Cells 
APC:  Low density ceils  Small B cells 
Responding  HT-2  HT-2  B cell 
cell: 
Antigen: 
--  +  --  +  --  + 
cpm 
T  cell hybridoma: 
B14  290  28,000  4,900  64,100  6,100  52,150 
2H10  550  8,300  340  6,800  13,800  44,700 
C10  270  54,600  1,500  54,900  11,500  79,000 
2B4  600  41,100  3,300  3,400  6,000  7,000 
Four different B10.A-derived T  cell hybridomas were tested for their ability to respond to either 
low density APC or small resting B cell APC with the production of IL-2 or the induction of syngeneic 
B cell proliferation.  1 X 105 T  cells were incubated with either 5 x  104 low density APC per well or 
2 x  l0  s small resting B cells per well. Each T  cell hybridoma was irradiated with 10,000 rads before 
assay.  IL-2 production was assessed by removing supernatant  from the stimulated T  cell cultures at 
24  h  and  testing  its  ability  to  cause  proliferation  of the  IL-2-dependent  T  cell,  HT-2.  B  cell 
proliferation was assessed by pulsing the original culture wells with tritiated thymidine as described 
in Materials and  Methods.  None of the APC in these assays  were irradiated.  The antigen used for 
B14 and C10 was HEL. The antigen used for 2H10 and 2B4 was pigeon cytochrome c fragment 81- 
104. 
pigeon  cytochrome c)  for  both  IL-2  production  and  recruitment  of B  cell 
proliferation. The cytochrome c-specific hybrid 2B4 failed to respond to normal 
B cells and antigen in either assay. In order to determine whether the 2B4 hybrid 
could recruit B cells if adequately stimulated, 5 x  104 syngeneic low density APC 
treated with  3,300  rads  were cultured with  2  ×  105  syngeneic small  resting 
B10.A B cells in the presence or absence of pigeon cytochrome c. Despite the 
fact  that  the  2B4  hybrid  produced  IL-2  (no  antigen,  420  cpm  of  [3H]- 
thymidine  incorporated  by  HT-2;  with  antigen,  5,200  cpm),  there  was  no 
recruitment of B cell proliferation in the presence of cytochrome c (no antigen, 
1,700  cpm of [3H]thymidine incorporated by the B cells;  with antigen,  2,100 
cpm). 
The experiment shown in Table VI demonstrates that both Sephadex G-10- 
passed B cells and the more highly purified panned B cells were equally capable 
of inducing  the  T  cell  hybrid  C10  to  produce  IL-2  in  the  presence  of the 
appropriate foreign antigen (HEL). The 2B4 hybrid again failed to secrete IL-2 
in response to either Sephadex G-10-passed or panned B cells as APC. It should 
also be noted that in the experiments displayed in  Tables V  and VI, all APC 
were unirradiated. Therefore it is not possible that the difference seen in the 
response of 2B4 cells to B cells compared to dendritic- and macrophage-enriched 
cells as  APC  was  due  to  the  differential radiation  sensitivity of the  antigen- 
presenting functions of these cells. 
It appears that the 2B4 hybrid is both incapable of secreting IL-2 when B cells 
are used as APC and unable to produce B cell recruiting factor(s) when stimulated 
with low density APC plus antigen. This presumably reflects two distinct differ- 
ences between 2B4 cells and the other T hybridomas tested: a failure to recognize 894  ANTIGEN PRESENTATION BY  RESTING B CELLS 
TABLE VI 
2B4 T Cell Hybrid Fails to Respond to B Cells as APC 
T  cell 
hybrid  No. of APC 
APC population: 
G-10 B ceils  Panned B cells  Low density ceils 
Antigen:  Antigen:  Antigen: 
-  +  -  +  -  + 
C10 
2B4 
1 ×  104  3,100'  83,500  3,000  18,000  --*  -- 
5 x  104  6,100  256,000  3,800  264,000  2,300  250,000 
1 ×  105  6,100  229,000  4,200  269,000  --  -- 
2 ×  105  3,100  205,000  3,300  235,000  4,100  191,000 
1 x  104  2,400  2,800  3,000  4,500  --  -- 
5 x  104  2,400  2,500  4,900  6,200  2,600  119,000 
1 x  105  --  2,900  4,600  6,700  --  -- 
2 x  105  2,400  7,100  4,400  6,300  1,500  81,000 
4 x  105  --  2,700  .... 
The ability of the T  cell hybrids C10 and 2B4 to secrete IL-2 in response to foreign antigen in the 
presence of different APC was tested. None of the APC were irradiated. The antigen used for 
2B4 was the pigeon cytochrome c fragment 81-104 and that used for C10 was HEL. 
*  Not determined. 
*  Proliferation of the cell HT-2 as a measure of the amount of IL-2 secreted by the T  cell hybridoma 
was performed as described in Materials and Methods and is expressed as cpm of [SH]thymidine 
incorporated. 
B  cells  as  APC  for  lymphokine  production,  and  a  failure  to  produce  B  cell 
recruiting factor(s) even when successfully stimulated to produce IL-2. 
Distinct Pathways in the T  Cell Exist for B  Cell-induced  T  Cell Proliferation and B 
Cell Recruitment.  11.4  and  PC.3.3  cells,  two of the  normal  T  cell clones that 
exhibited different phenotypes, as judged by their ability to proliferate when B 
cells were used as APC (Table IV), were selected for further analysis.  Fig.  5A 
presents an experiment in which various potential antigen-presenting populations 
were used in the presence of GAT to induce T  cell proliferation of clone  11.4. 
Increasing numbers of T-depleted spleen cells were effective in causing  11.4 T 
cells to incorporate [SH]thymidine. The low density dendritic- and macrophage- 
enriched  cell  population  was  much  more  potent  than  the  T-depleted  whole 
population (approximately eightfold on a per cell basis). The small resting B cells 
taken from the Percoll gradient, as well as B cells further purified over Sephadex 
G-10, failed to cause  11.4  T  cells to take up [SH]thymidine in the presence of 
GAT  at  any  cell  number  tested,  up  to  3  X  105  per  well.  A  simultaneous 
experiment with irradiated  11.4 T  cells confirmed that 2 x  105 Sephadex G-10- 
passed B cells were quite effective at presenting antigen for their own recruitment 
(no GAT, 2,800 cpm; with GAT, 60,000 cpm). Furthermore, it should be noted 
that the inability of B cells to act as APC for the induction of proliferation of the 
T  cell clone  11.4 is in striking contrast to the earlier experimental result shown 
in Fig. 4, namely, that the B cell-enriched and the macrophage- and dendritic 
cell-enriched populations were equivalent in stimulating  11.4 T  cells to recruit 
B10.S(9R)  B  cell  proliferation.  Thus,  11.4  is  capable  of responding  to  B  cell 
APC by producing  B  cell recruitment  factor(s) but not by incorporating  [SH]- 
thymidine. ASHWELL  ET  AL.  895 
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FIGURE 5.  T cell PC.3.3 but not T cell 11.4 proliferates when stimulated with antigen in the 
presence of B  cells.  2  x  104 T  cells  were  incubated with  various B10.A APC at  varying 
numbers plus or minus antigen: GAT, 100 #g/ml for 11.4 in Panel A or pigeon cytochrome 
c, 30 #g/ml for PC.3.3 in Panel B. Low density APC (3,300 rads) (O----O), T-depleted spleen 
cells  (3,300  rads)  (Ig---Q), small resting  B  cells  taken  from  Percoll  gradient (1,000  rads) 
(&--A), small resting B cells taken from Percoll and passed over Sephadex G-10 (1,000 rads) 
(A--A), panned B cells (1,000 rads) (if]--C1). 
In  contrast,  the  other  B10.A-derived  T  cell  clone,  PC.3.3,  was  shown  to 
proliferate quite well when panned B cells, the most highly purified B cells used 
in these experiments, were used to present antigen (Fig.  5B).  This population 
presented antigen as well as T-depleted spleen, but was significantly less potent 
(~ 10-fold) than dendritic- and macrophage-enriched cells. Panned B cells caused 
a small but significant antigen-induced [aH]thymidine incorporation by T  cells 
(Acpm 2,300) even at 3  X  10 a B cells per well. This is similar to the minimum 
number of B cells required to obtain B10.S(9R) B cell recruitment by the 11.4 
T  cells (Fig. 3). 
The inability of 11.4 T  cells to proliferate when resting B cells were used as 
APC was not due to the unusual conditions under which these cells were grown. 
To  show this,  a  variant of 11.4,  11.4F,  was grown by alternating periods  of 
stimulation with GAT plus 3,300 rads irradiated syngeneic spleen cells followed 
by rest with spleen cells and no antigen.  No exogenous IL-2  was required to 
grow these cells. The comparative ability of different APC to cause proliferation 
of 11.4F T  cells is shown in Table VII. The  11.4F cells failed to take up [3H]- 
thymidine when B cells were used as APC,just as was true of the IL-2-dependent 
11.4 T  cells. At the same time,  11.4F T  cells, when stimulated with GAT and 
purified B cells, were capable of causing B cell proliferation (Table VII). 
Taken together, these data suggest that the pathways by which the cloned T 
cells  are  induced  by  antigen  and  APC  to  either  proliferate  or  to  produce 
activation factor(s) for B cell recruitment must be distinct. 
B  Cells Can Present Soluble Antigen  to Primed Lymph Node T  Cells.  Although it 
has been shown that highly purified resting B cells can present antigen to in vitro 896  ANTIGEN  PRESENTATION  BY  RESTING  B  CELLS 
TABLE  VII 
11.4F T Cell Clone Responds to B Cells as APC to Give B Cell Recruitment But Not T Cell 
Proliferation 
APC 
GAT:  T cell no.  No. of APC  T-depleted spleen  Low density cells  Sephadex  G-10  Panned B 
(3,300  rads)  (3,300  rads)  (1,000  racks)  (1,000  rads) 
--  +  --  +  --  +  --  + 
Tcell 
[3H]thymidine 
incorporation (cpm) 
B cell  11.4F 
[SH]thymidine  (2,000  rads) 
incorporation (cpm)  3 x  lO  s  2 x  lO  s 
1 X 104  2 x  lO  s 
3 x 104  2 x  10  s 
11.4F 
(Unirrad.) 
2 x  104  I x  10  s  230  2,100  1,600  25,500  100  380  140  340 
2 x  104  2 x  10  s  490  5,500  2,300  15,800  100  340  330  210 
2 x  104  4 ×  10  s  900  7,800  460  10,600  --  --  260  420 
Scphadex  G-10 
(Unirradiated) 
3,400  5,700 
4,260  9,670 
4,930  21,820 
T  cell proliferation: 2 ×  104 11.4F T  cells per well were cultured with varying numbers of APC in the presence  or absence  of GAT (I00 ~ag/ 
ml). T  cell proliferation in the absence  of any added APC was 160 cpm in the presence  of GAT. B cell proliferation: 11.4F was treated with 
2,000 rads and cultured at the numbers indicated in the presence  of 2 ×  105 Sephadex  G-10-passed unirradiated B cells. The concentration 
of GAT was 100 ~g/ml. 
T  cell clones maintained by a variety of different culture techniques, it might be 
argued that normal T  cells freshly harvested from an immunized animal require 
activation signals that only macrophages or dendritic cells can provide. In order 
to test this possibility,  T  cells were isolated from the lymph nodes of purified 
protein derivative (PPD)-primed B10.A  mice by passage over nylon wool col- 
umns and treatment with anti-Ia antibody plus complement. These T  cells were 
then cultured with either lightly irradiated (1,000 rads) Sephadex G-10-passed 
B cells or heavily irradiated (3,300  rads) T-depleted whole spleen cells in  the 
presence or absence of PPD (Fig.  6).  Both  lightly irradiated Sephadex G-10- 
passed B cells and T-depleted spleen cells were capable of inducing the purified 
lymph node T  cells to proliferate in the presence, but not the absence, of PPD. 
The T  cell response was directly related to the number of APC added. Although 
the Sephadex G-10-passed cells were clearly quite capable of presenting PPD 
for T  cell proliferation, they appeared to be about two- to threefold less efficient 
than T-depleted whole spleen cells. The modest difference in potency of these 
two populations may reflect either the superiority of low density, radioresistant 
APC over B cells as APC for T  cell proliferation, or the ability of only a subset 
ofT cells in the whole population to utilize B cells for this function. The dramatic 
reduction  (at  least  30-fold)  in  the  ability  of heavily  irradiated  (3,300  rads) 
Sephadex G-10-passed B cells, in comparison to lightly irradiated (I,000 rads) 
B cells, to induce T cell proliferation eliminates the possibility that contaminating 
low density radioresistant cells (i.e., macrophages or dendritic cells) in the B cell 
population were responsible for the stimulatory activity. Experiments in which 
panned B cells were used to present PPD to antigen-primed T  cells gave similar 
results. Thus, we conclude that purified small resting B cells are fully capable of 
presenting antigen even to T  lymphocytes freshly explanted from the animal as 
long as the B cells have not been irradiated with >1,000 rads. ASHWELL  ET  AL.  897 
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FIGURE 6.  Small resting B cells can present soluble antigen to primed T  cell populations. T 
cells were prepared from the draining lymph nodes of PPD-primed B10.A mice by passage 
over nylon wool and treatment with anti-Ia monoclonal antibodies plus complement. 4 x  105 
T  cells per well were incubated with varying numbers  of different B10.A APe. The wells 
were pulsed  with  [SH]thymidine at  72  h  and  harvested  16  h  later.  T-depleted spleen cells 
(3,300  rads)  (t~--O),  Sephadex  G-10-passed  B  cells (1,000  rads)  (O---O),  Sephadex  G-10- 
passed B cells (3,300 rads) (A--A). The [] represents the A cpm in the absence of any added 
APC. 
Discussion 
In this report we have shown that highly purified small resting B cells from 
normal unprimed spleen are capable of presenting foreign antigen to a  variety 
of MHC-restricted T  cell clones to cause both T  cell proliferation and T  cell- 
dependent  B  cell  stimulation,  as  measured  by  the  latter's  enlargement and 
proliferation. The ability of B cells to present foreign antigen to MHC-restricted 
T  cells has been previously examined by a  number of other investigators.  In 
1980 Kammer and Unanue (13) prepared nonadherent cells from whole spleen, 
passed them over a  Sephadex G-10 column, and then selected for IgM-positive 
cells by cytofluorometric cell sorting. These cells were treated with mitomycin c 
and used as APe in a  T  cell [SH]thymidine incorporation assay. KLH-primed 
lymph node T  cells proliferated when incubated with these cells in the presence 
of KLH;  however, peritoneal exudate cells were more than  10-fold better at 
inducing this activity. Although these data were consistent with the hypothesis 
that normal B cells could present antigen to T  cells, the authors felt that because 
peritoneal exudate cells were so much more effective as APC than the cells in 
the B cell preparation,  they could not definitely exclude the possibility that a 
small  degree of contamination with  macrophages or other accessory cells ac- 
counted for the apparent antigen-presenting activity of their B cells. This doubt 
has been eliminated in our studies by demonstrating the radiosensitivity of B cell 898  ANTIGEN PRESENTATION BY  RESTING B CELLS 
antigen presentation, a  characteristic that dendritic cells and macrophages do 
not share. 
Chesnut and Grey (19) compared 4,500 rads irradiated adherent spleen cells 
with 4,500 rads irradiated macrophage-depleted (Sephadex G-10-passed) spleen 
cells  for  their  ability  to  present  antigen  to  rabbit  gamma  globulin  primed 
syngeneic T  cell populations.  They found that in  in  vitro T  cell proliferation 
assays, rabbit Ig was effectively presented to T  cells from rabbit Ig-immunized 
donors only by the splenic adherent cells.  In contrast, the rabbit anti-mouse Ig 
stimulated comparable amounts of T  cell proliferation whether splenic adherent 
cells or  macrophage-depleted spleen  cells were used as APC.  This  result was 
interpreted as implying that under certain circumstances (e.g. when the B cell 
immunoglobulin receptor could bind  the antigen recognized by the T  cell) B 
cells are capable of acting as APC for T  cell proliferation. In a subsequent paper, 
experiments were presented in which LPS B cell blasts and B cell lymphomas, 
but not normal B cells, were capable of presenting the antigen KLH to either 
KLH-specific  T  cell  hybridomas or  KLH-primed  normal  T  cell  populations. 
Taken together, these reports would suggest that only under unusual circum- 
stances do small resting B cells effectively present antigen to T  cells for T  cell 
proliferation. 
The discrepancies between the conclusions reached in  this paper and those 
cited above can be accounted for in a  number of ways. We find that antigen 
presentation by small resting B cells is quite radiosensitive, in  contrast to  the 
presentation by low density splenic APC or B cell tumors (7,  17, 37). Radiation 
doses  of as  little  as  1,500  rads  significantly  reduced  the  antigen-presenting 
capability of small resting B cells, and doses of over 2,000 rads totally abrogated 
it.  Thus,  experiments performed with  heavily irradiated  APC  would  not  be 
expected to show that small resting B cells can present antigen. The finding that 
LPS blasts, but not resting B cells, are capable of presenting antigen to T  cells 
might  reflect  an  enhanced  antigen-presenting  capacity  of activated  B  cells. 
Chesnut et al.  (18) found that LPS-blasts bound ~ 10-fold more of the labeled 
antigen  than  did  resting  B  cells.  Another possible  mechanism for  enhanced 
antigen presentation by LPS  B cell blasts is suggested by the observation that 
stimulation  of B  cell  populations  with  LPS  and  dextran sulfate results  in  an 
increased expression of Ia molecules by these cells as they progress through the 
G1  phase  of the cell cycle (38).  Finally,  the antigen-presenting ability of LPS 
blasts may be less radiosensitive than that of normal B cells. 
An apparent  exception to  the observation that  heavily irradiated resting B 
cells cannot present antigen to T  cells is the ability of B cells to present rabbit 
anti-mouse immunoglobulin to normal rabbit gamma globulin-primed T  cells. 
However, in a recent report, Kakiuchi et al. (39) found that the presentation of 
rabbit anti-mouse immunoglobulin required prolonged exposure of the B cells 
to antigen, with the optimum attained at 16 h. It was also found that incubation 
of OVA-primed T  cells (which contained 1% contaminating B cells) with rabbit 
anti-mouse immunoglobulin F(ab')~ in  the absence of additional APC allowed 
OVA to induce substantial T  cell proliferation. This was interpreted to mean 
that  the B  cell APC  required preactivation (in  this case by rabbit anti-mouse 
immunoglobulin) before  they  could  present  antigen.  If this  is  the  case,  the ASHWELL  ET  AL.  899 
antigen-presenting  function  of these cells may be more similar to that  of LPS 
blasts than to that of the small resting B cells studied in this paper. 
The mechanism by which irradiation impairs the ability of small resting B cells 
to act as APC is not clear.  It appears that  lymphocytes are very susceptible to 
radiation damage while in interphase.  Anderson et al. (40) examined the effects 
of irradiation  on the  viability and  migration  in  vivo of T  and  B  lymphocytes. 
They found that  90%  of unactivated  T  cells (thoracic  duct lymphocytes from 
CBA mice) were killed by 300 rads, as compared to the death of 99% of B cells 
(thoracic duct lymphocytes from CBA nu/nu mice). They also observed that the 
in vivo migration of resting B cells to lymphoid organs was much more radiosen- 
sitive than  that  of resting  T  cells.  Rahmsdorf et al.  (41)  studied  the  in  vitro 
effects of gamma irradiation  on T  cells, B cells, and fibroblasts. They observed 
that the ability of fibroblasts to synthesize DNA was approximately fivefold more 
radioresistant than that ofT cells, which, in turn, was twofold more radioresistant 
than that of B cells. The authors speculated that the differences in radiosensitivity 
between the cell types reflected differences in their ability to repair  radiation- 
inflicted  damage.  However,  measurement  of single  and  double-strand  DNA 
breakage and  of unscheduled  DNA synthesis (as  a  measure  of the excision of 
modified  bases from  the  DNA  and  their  resynthesis)  revealed  no  differences 
between the cell types examined. Overall, these data suggest that B lymphocyte 
viability, as well as at least some function, such as in vivo migration (and perhaps 
injury repair),  is especially radiosensitive.  The  findings reported  in  this  paper 
would now add antigen  presentation  to the  list of radiosensitive  B lymphocyte 
functions. 
Reports by Katz et al. (20) and Bandeira et al. (22) have shown that normal B 
cells can indeed act as APC for the initiation of T  cell function, but that they are 
only effective in inducing the T  cells to recruit B cells. In the former case, long- 
term in vitro IL-2-dependent, OVA-specific, T  cell clones were found to prolif- 
erate in  the presence of OVA and  mitomycin c-treated splenic adherent  cells, 
but not mitomycin c-treated B cells recovered from anti-mouse Ig-coated plastic 
dishes.  When  the  T  cells and  not  the  B  cells were treated  with  mitomycin  c, 
however,  the  B  cells were found to proliferate.  Bandeira  et al.  examined  the 
ability of Sephadex G-10-passed cells to stimulate either antigen-specific T  cell 
proliferation or syngeneic B cell proliferation. They found that irradiated (2,000 
rads) B cells were incapable of promoting T  cell proliferation, although irradiated 
T  cells  caused  a  vigorous  recruitment  of unprimed  B  cells.  The  results  of 
Bandeira et al. might be explained by the radiosensitivity of the B cell antigen- 
presenting  function.  However, the  observations of both  papers  might  also be 
explained by our finding that there seem to be a number of different phenotypes 
exhibited by different T  cell clones. The first, exemplified by the cells A.5.1 and 
PC.3.3,  is that  of a  T  cell that  can proliferate  well to the appropriate  foreign 
antigen  plus B cell APC. A  second phenotype, seen in  11.4, is that of a  T  cell 
that does not proliferate when B cells are used as APC, even though B cells serve 
as excellent stimulators of both syngeneic and allogeneic B cell recruitment  by 
the T  cell.  It is this  phenotype that  may have been studied by Katz et at.  and 
Bandeira et al. 
The  existence of two T  cell phenotypes suggests that  there  must be at  least 900  ANTIGEN  PRESENTATION  BY  RESTING  B  CELLS 
two distinct activation pathways stimulated by the APC. One pathway leads the 
T  cell to secrete a  factor(s) that causes B cells to enlarge, proliferate, and, as 
described in the accompanying paper (36), differentiate into antibody-secreting 
cells.  Although  we  have  not  yet demonstrated  that  the actual  lymphokine(s) 
responsible for these effects are all T  cell-derived, it is clear that in the system 
described, an MHC-restricted antigen-specific T  cell is required at some point in 
the pathway that leads to polyclonal B cell activation. The other pathway initiated 
by the APC in the presence of the appropriate antigen leads to T  cell prolifera- 
tion.  Although  11.4  T  cells can clearly be stimulated to proliferate when the 
signal  is  delivered  from  a  low  density  radioresistant  cell,  it  is  incapable  of 
responding to a similar signal from a B cell. Whether this is due to a qualitative 
or quantitative  difference between the low density APC  and  B  cell signals  is 
unknown. Clearly, however, many other T  cells exhibit a  phenotype distinct 
from 11.4 T  cells, as they are quite capable of receiving the proliferation signal 
from B cell APC. 
A third T  cell phenotype, seen in the T  cell hybridoma 2B4, is that of a cell 
that does not respond to B cell APC plus foreign antigen by producing IL-2. In 
addition, 2B4 does not seem to secrete any B cell recruiting factors, even when 
stimulated  to  make  IL-2  by  low  density  radioresistant  APC.  This  cell  may 
therefore exhibit two "defects": the failure to respond to B cell APC by producing 
IL-2, and the inability to make B cell recruiting factor(s) even when adequately 
stimulated to make other lymphokines. Whether this phenotype is truly a third 
subpopulation of T  cells or only a somatic variant that arose in culture, remains 
to be determined. 
Even though the resting B cells used in  these experiments were extensively 
purified, it might be argued that a  very small number of contaminating non-B 
cells present  in  the  stimulating  population  were responsible  for the antigen- 
presenting activity measured. We feel this is unlikely for several reasons. First, 
the cells in  the purified B  cell population  that were found to present antigen 
could be  distinguished  from the  more conventional APC  present  in  the low 
density fraction of the Percoll gradient by their differential activation of several 
of the T  cell clones assayed. As discussed above,  the  11.4  T  cell proliferated 
vigorously in the presence of foreign antigen and low density APC, but not at 
all to the B cell-enriched populations.  In contrast, T  cells PC.3.3  proliferated 
well when either population was used as APC. Second, the APC found in the B 
cell population were radiosensitive. This excludes the possibility that "traditional" 
APC such as macrophages or dendritic cells contaminate the B cell populations 
and are responsible for the antigen presentation. Such cells, which are present 
in  both  the  T-depleted spleen  cells and the low density cells taken from the 
Percoll gradient,  were tested in  parallel with the high-density B cell-enriched 
populations and shown to be very radioresistant. These data indicate that two 
distinct APC present in normal spleen are capable of presenting antigen to MHC- 
restricted T  cells. Since the most purified cells used, those recovered from anti- 
immunoglobulin-coated dishes, were >99%  B cells as determined by cytofluo- 
rometric  analysis and  as  few  as  2  x  103  of them  were  sufficient to  elicit  a ASHWELL ET AL.  901 
detectable T  cell response (Figs.  3  and 5),  the simplest interpretation of these 
observations  is  that  resting  B  cells  themselves constitute  one  of these  APC 
populations. 
We also observed that small resting B cells could present soluble antigen to an 
antigen-primed T  cell population.  Heavily irradiated T-depleted whole spleen 
cells were potent stimulators;  lightly irradiated Sephadex G-10-passed  B cells 
were only two- to threefold less efficient. The radiosensitivity of the B cell APC 
at 3,300 rads demonstrated that their antigen-presenting activity was not due to 
contaminating  low  density  APC  in  the  B  cell  population.  This  observation 
supports  the notion that antigen presentation by resting B cells is not due to 
some unusual property of in vitro long-term T  cell lines and clones, but in fact 
occurs with normal antigen-specific T  cells freshly taken from the animal. 
The observation that small resting B cells can act as APC for T  cell activation 
implies that, in contrast to the results of Chesnut and Grey, unactivated cells can 
perform whatever antigen ~processing" functions are required in order for T 
cells to recognize the antigen in association with class  II restriction elements. 
Thus,  the  possibility  that  B  cells  are  responsible  for  antigen-driven  T  cell 
activation must be taken into consideration in studies dealing with T  ceil-B cell 
collaboration. Apparently MHC-restricted T  cell-B cell interaction may, in some 
systems, reflect MHC-restricted T  cell activation by B cells rather than MHC- 
restricted T  cell-induced B cell activation (36). Whether resting B cells can act 
as APC for resting (e.g. virgin) T  cells has not been directly addressed in these 
experiments since it may be argued that none of the T  cells used in these studies 
are truly resting (42). 
Finally, the finding that two distinct pathways of T cell activation exist suggests 
that B cells and low density APC differ in at least some aspects of their antigen 
presentation. This might be due to different supplementary APC signals (such 
as lymphokines), which initiate different T  cell functions (i.e., T cell proliferation 
and lymphokine release). The difference observed in the ability of the different 
APC  to  initiate  distinct  T  cell  activation  pathways  may  reflect  quantitative 
differences in  either the ability of the APC  to deliver these signals or of the 
individual T  cell clones to  receive them.  Further  studies will  be  required to 
differentiate between these possibilities. 
A  question that is still  not completely answered is whether macrophage and 
dendritic cells alone can serve as stimulators for T cell-driven B cell recruitment. 
Attempts to completely purify these cells away from surface immunoglobulin- 
positive cells have so far been  only partially successful.  One observation that 
suggests that they may indeed be capable of this activity is that low density cells 
treated with 3,300 rads did cause allogeneic B cells to proliferate when used as 
stimulators for antigen-specific T  cells (Fig.  4).  Since B cell antigen-presenting 
function was shown to be eliminated by this dose of irradiation (Table II and 
Fig.  2),  the remaining antigen-presenting activity is likely to be attributable  to 
dendritic cells or macrophages. This question, as well as the evaluation of what 
soluble factors may be involved in T  and B cell stimulation, is currently being 
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Summary 
In this report  we have examined the ability of small resting B  cells to act as 
antigen-presenting  cells  (APC)  to  antigen-specific  MHC-restricted  T  cells  as 
assessed by either T  cell proliferation or T  cell-dependent B  cell stimulation. 
We found that  10  of 14 in vitro antigen-specific MHC-restricted T  cell clones 
and  lines  and  three  of  four  T  cell  hybridomas  could  be  induced  to  either 
proliferate  or  secrete  IL-2  in  the  presence  of lightly irradiated  (1,000  rads) 
purified  B  cells  and  the  appropriate  foreign  antigen.  All  T  cell  lines  and 
hybridomas were  stimulated to proliferate or make IL-2 by macrophage- and 
dendritic cell-enriched populations and all T  cells tested except one hybridoma 
caused  B  cell  activation  when  stimulated with  B  cells  as  APC.  Furthermore, 
lightly irradiated,  highly purified syngeneic B  cells were as potent a  source of 
APC for inducing B cell activation as were low density dendritic and macrophage- 
enriched cells. Lymph node T  cells freshly taken from antigen-primed animals 
were  also  found  to  proliferate  when  cultured  with  purified  B  cells  and  the 
appropriate antigen. Thus, small resting B cells can function as APC to a variety 
oft  cells. This APC function was easily measured when the cells were irradiated 
with 1,000 rads, but was greatly diminished or absent when they were irradiated 
with  3,300  rads.  Thus,  the  failure of some other  laboratories  to observe  this 
phenomenon  may be  the  result of the  relative radiosensitivity of the antigen- 
presenting function of the B cells. In addition, this radiosensitivity allowed us to 
easily distinguish B cell antigen presentation from presentation by the dendritic 
cell and macrophage, as the latter was resistant to 3,300 rads. Finally, one T  cell 
clone that failed to proliferate when B cells were used as APC was able to recruit 
allogeneic  B  cells  to  proliferate  in  the  presence  of syngeneic B  cells and  the 
appropriate  antigen.  This  result  suggests  that  there  are  at  least  two  distinct 
pathways of activation in T  cells, one that leads to T  cell proliferation and one 
that leads to the secretion of B cell recruitment factor(s). 
We wish to thank Dr. Alfred Singer for critical review of this manuscript and Ms. Shirley 
Starnes for help in the preparation of the manuscript. 
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